Hypoxia induced by benign intestinal epithelial cells is associated with cyclooxygenase-2 expression in stromal cells through AP-1-dependent pathway

Oncogene

Volumn 25, Issue 23, 2006, Pages 3277-3285

  Uenoyama, Y ^a   Seno, H ^a   Fukuda, A ^a   Sekikawa, A ^a   Nanakin, A ^a   Sawabu, T ^a   Kawada, M ^a   Kanda, N ^a   Suzuki, K ^a   Yada, N ^a   Fukui, H ^a   Chiba, T ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cell density; Colorectal tumor; fibroblast

Indexed keywords

CYCLOOXYGENASE 2; OXYGEN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL POPULATION; CELL STRAIN CACO 2; CELL TRANSFORMATION; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FIBROBLAST; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; INTESTINE CELL; INTESTINE EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; UPREGULATION;

ANIMALS; ANOXIA; CACO-2 CELLS; CELL COUNT; CELL LINE, TUMOR; COCULTURE TECHNIQUES; CYCLOOXYGENASE 2; ENZYME INDUCTION; HUMANS; INTESTINAL MUCOSA; MEMBRANE PROTEINS; MICE; NIH 3T3 CELLS; PRECANCEROUS CONDITIONS; SIGNAL TRANSDUCTION; STROMAL CELLS; TRANSCRIPTION FACTOR AP-1;

EID: 33744912284     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209359     Document Type: Article

References (47)

1. Bates SE, Valverius EM, Ennis BW, Bronzert DA, Sheridan JP, Stampfer MR et al. (1990). Endocrinology 126: 596-607.
2. Boman BM, Walters R, Fields JZ, Kovatich AJ, Zhang T, Isenberg GA et al. (2004). Am J Pathol 165: 1489-1498.
3. Chapple KS, Scott N, Guillou PJ, Coletta PL, Hull MA. (2002). J Pathol 198: 435-441.
4. Coffey RJ, Hawkey CJ, Damstrup L, Graves-Deal R, Daniel VC, Dempsey PJ et al. (1997). Proc Natl Acad Sci 94: 657-662.
5. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. (1994). Gastroenterology 107: 1183-1188.
6. Fujita T, Matsui M, Takaku K, Uetake H, Ichikawa W, Taketo MM et al. (1998). Cancer Res 58: 4823-4826.
7. Gupta RA, Dubois RN. (2001). Nat Rev 1: 11-21.
8. Han C, Demertis AJ, Liu Y, Shelhamer JH, Wu T. (2004). J Biol Chem 279: 44344-44354.
9. Hanahan D, Folkman J. (1996). Cell 86: 353-364.
10. Hoper MM, Voelkel NF, Bates TO, Allard JD, Horan M, Shepherd D et al. (1997). Am J Respir Cell Mol Biol 17: 748-756.
11. Huang TS, Lee SC, Lin JK. (1991). Proc Natl Acad Sci 88: 5292-5296.
12. Jobin C, Haskill S, Mayer L, Panja A, Sartor RB. (1997). J Immunol 158: 226-234.
13. Kawada M, Seno H, Wada M, Suzuki K, Kanda N, Kayahara T et al. (2003). Digestion 67: 20-24.
14. Kim HJ, Kim TY. (2004). J Invest Dermatol 123: 547-555.
15. Kim H, Rhee SH, Kokkotou E, Na X, Savidge T, Moyer MP et al. (2005). J Biol Chem 280: 21237-21245.
16. Ko SCW, Chapple KS, Hawcroft G, Coletta PL, Markham AF, Hull MA. (2002). Oncogene 21: 7175-7186.
17. Kondoh N, Wakatsuki T, Ryo A, Hada A, Aihara T, Horiuchi S et al. (1999). Cancer Res 59: 4990-4996.
18. Li Q, Ahmed S, Loeb JA. (2004). Cancer Res 64: 7078-7085.
19. Liu W, Reinmuth N, Stoeltzing O, Parikh AA, Tellez C, Williams S et al. (2003). Cancer Res 63: 3632-3636.
20. Lu YP, Chang RL, Lou YR, Huang MT, Newmark KR, Conney AH. (1994). Carcinogenesis 15: 2363-2370.
21. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM et al. (2000). Cancer Res 60: 1306-1311.
22. Montano X, Djamgoz MBA. (2004). FEBS Letters 571: 1-8.
23. Nordsmark M, Overgaard M, Overgaard J. (1996). Radiother Oncol 41: 31-39.
24. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E et al. (1996). Cell 87: 803-809.
25. Oshima M, Oshima T, Taketo MM. (2005). Biochem Biophys Res Commun 330: 928-933.
26. Park CH, Lee JH, Yang CH. (2005). J Biochem Mol Biol 38: 474-480.
27. Preston SL, Wong WM, Chan AOO, Poulsom R, Jeffery R, Goodlad RA et al. (2003). Cancer Res 63: 3819-3825.
28. Ricci P, Di Palma A, Acquaviva AM. (2003). Br J Cancer 88: 803-807.
29. Salomon DS, Brandt R, Giardiello F, Normanno N. (1995). Crit Rev Oncol Hematol 19: 183-232.
30. Schmedtje Jr JF, Ji YS, Liu WL, Dubois RN, Runge MS. (1997). J Biol Chem 272: 601-608.
31. Seno H, Oshima M, Ishikawa T, Oshima H, Takaku K, Chiba T et al. (2002). Cancer Res 62: 506-511.
32. Sheares KK, Jeffery TK, Long X, Morrell NW. (2004). Am J Physiol Lung Cell Mol Physiol 287: L919-L927.
33. Sheta EA, Trout H, Gildea JJ, Harding MA, Theodorescu D. (2001). Oncogene 20: 7624-7634.
34. Slice LW, Chiu T, Rozengurt E. (2005). J Biol Chem 280: 1582-1593.
35. Smith WJ, DeWitt DL, Garavito RM. (2000). Annu Rev Biochem 69: 145-182.
36. Sonoshita M, Takaku K, Sasaki N, Sugimoto Y, Ushikubi F, Narumiya S et al. (2001). Nat Med 7: 1048-1051.
37. Tamura M, Sebastian S, Yang S, Gurates B, Ferrer K, Sasano H et al. (2002). J Biol Chem 277: 26208-26216.
38. Tanaka Y, Kobayashi H, Suzuki M, Kanayama N, Terao T. (2004). J Biol Chem 279: 8567-8576.
39. Tokuda Y, Crane S, Yamaguchi Y, Zhou L, Falanga V. (2000). J Cell Physiol 182: 414-420.
40. Vila-del Sol V, Fresno M. (2005). J Immunol 174: 2825-2833.
41. Vultur A, Cao J, Arulanandam R, Turkson J, Jove R, Greer P et al. (2004). Oncogene 23: 2600-2616.
42. Williams CS, Tsuji M, Reese J, Dey SK, DuBois RN. (2000). J Clin Invest 105: 1589-1594.
43. Wu G, Mannam AP, Wu J, Kirbis S, Shie JL, Chen C et al. (2003). Am J Physiol Heart Circ Physiol 285: 2420-2429.
44. Xie W, Herschman HR. (1996). J Biol Chem 271: 31742-31748.
45. Xu Q, Ji YS, Schmedtje Jr JF. (2000). J Biol Chem 275: 24583-24589.
46. Yarden Y, Sliwkowski MX. (2001). Nat Rev Mol Cell Biol 2: 127-137.
47. Zhang KX, Ward KR, Schrader JW. (2004). Mol Cancer Res 2: 242-255.